Former CEO and Director · Perspective Therapeutics, Inc. (CATX)

Lori Woods

A named executive officer of Perspective Therapeutics in every fiscal year CompBrief holds from FY2018 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$671,732

Salary $69,785Stock awards $0

FY2022: $768,694

4th of 4 named executive officers at Perspective Therapeutics by FY2023 total.

4 named officers on file for Perspective Therapeutics, FY2023

Lori Woods’s pay file — $29

  • 6 fiscal years of pay, line by line
  • CATX’s disclosed peer group of 25 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Perspective Therapeutics’s whole pay program stands against its peers

  • Perspective Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on CATX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 18, 2024 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Lori Woods’s full pay file as a PDF — free

More than this page: up to 10 years of Lori’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Lori Woods compensation by year

Perspective Therapeutics Summary Compensation Table · all 6 fiscal years held
In US dollars, as Perspective Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2018FY2019FY2020FY2021FY2022FY2023
Salary$23,064$315,612$315,612$353,450$439,816$69,785
Bonus$0$0$0$0——
Stock awards$0$0$0$0$0$0
Option awards$83,875$74,700$98,700$0$279,648$0
Non-equity incentive$971$15,781$77,325$17,745$46,180$0
Pension and deferred compensation$0$0$0$0$0$0
All other$0$10,431$0$0$3,050$601,947
Total$107,911$416,524$491,637$371,195$768,694$671,732

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Perspective Therapeutics, Inc. DEF 14A filed April 18, 2024, accession 0000950170-24-045554, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Perspective Therapeutics, Inc. filed document, accession 0000950170-24-045554. Every figure is read from that document and cited to the page and table it appears in. Filed April 18, 2024.

$108K
$417K
$492K
$371K
$769K
$672K
FY18
FY19
FY20
FY21
FY22
FY23
SalaryNon-equity incentiveOption awardsAll other

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
Option230,000—$0.38
Option339,444—$0.38
Option230,000—$0.24

Per the Outstanding Equity Awards at Fiscal Year-End table in Perspective Therapeutics, Inc.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

10 Form 4 lines since the FY2023 proxy (filed April 18, 2024)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
—————48,076
—————1,553,984
2026-11-12Purchase—23,750$0.8428,557
2026-03-02Grant or award derivative—50,000$0.0050,000
2025-03-31Purchase—23,475$2.13183,460
2025-03-03Grant or award derivative—50,000$0.0050,000
2024-06-20Grant or award derivative—23,000$0.0023,000
2024-06-14Purchase—83$10.80159,985

The 8 most recent of 10 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Perspective Therapeutics’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Johan SpoorCEO and Director$1,458,996
Jonathan HuntChief Financial Officer$1,169,963
Markus PuhlmannChief Medical Officer$900,093
Lori Woods · this pageFormer CEO and Director$671,732

Board service

Perspective Therapeutics board · FY2024–FY2025
Director compensation in US dollars, as Perspective Therapeutics reports it. Most recent year first; a dash means the company reported no figure in that column.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$90,000$0$99,397$0$189,397
FY2024$90,000$0$192,540$0$282,540

Each year as the company reported it in Perspective Therapeutics's director compensation table. Totals are the company's own disclosed totals.

How this board is paid

Company policy: Perspective Therapeutics pays directors a $60,000 cash retainer and $99,397 in equity. As stated in Perspective Therapeutics's FY2025 proxy.

The full Perspective Therapeutics compensation record

free company brief

This page is one person within Perspective Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Perspective Therapeutics proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Perspective Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Lori Woods's compensation dossier · One-time report. No refunds.